Convergence and Divergence in the Neurochemical Regulation of Prepulse Inhibition of Startle and N40 Suppression in Rats

Overview

Journal Neuropsychopharmacology

Date 2005 Aug 27

PMID 16123772

Citations 19

Authors

Neal R Swerdlow

Mark A Geyer

Jody M Shoemaker

Gregory A Light

David L Braff

Karen E Stevens

Richard Sharp

Michelle Breier

Alaina Neary

Pamela P Auerbach

Affiliations

Soon will be listed here.

Abstract

Prepulse inhibition of startle ('PPI'), a cross-species measure of sensorimotor gating, is impaired in schizophrenia patients. Suppression of P50 event-related potentials (ERPs) in response to the second of two clicks ('P50 gating') is also impaired in schizophrenia. Suppression of N40 ERPs to the second of two clicks ('N40 gating') is thought by some to be a rat homolog of human P50 gating. Emerging evidence suggests differences in the neurobiology of deficits detected by PPI vs P50 (or N40) gating. We recorded PPI and N40 gating contemporaneously in rats, to assess convergence and divergence in the neurochemical regulation of these measures. Dose-response studies examined the effects of apomorphine (APO), phencyclidine (PCP) or the 5HT2A agonist DOI on PPI, and on motor responses to stimuli (S1 and S2) that elicit N40 gating. Effects of optimal drug doses on PPI and N40 gating were then assessed in other rats with implanted cortical surface electrodes. APO, PCP and DOI caused dose-dependent disruptions of both PPI and gating of motor responses to N40 stimuli. Reduced PPI reflected diminished prepulse effectiveness, demonstrated by increased startle levels on prepulse+pulse trials. In contrast, reduced gating of motor responses to N40 stimuli reflected a reduced motor response to S1. In separate rats, robust PPI, N40 potentials and N40 gating could be detected within one test. PPI and N40 gating were disrupted by APO, PCP, and DOI. Again, drug effects on PPI reflected increased startle on prepulse+pulse trials, while those on N40 gating reflected reduced ERP responses to S1. In conclusion, when PPI and N40 gating were studied concurrently in rats, drug effects on PPI reflected reduced inhibition of startle by the prepulse, while diminished N40 gating reflected S1 response suppression. Despite similarities in drug sensitivity, these results suggest that distinct neurobiological mechanisms underlie drug-induced deficits in PPI and N40 gating.

Citing Articles

Effect of Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs.

Tirri M, Bilel S, Arfe R, Corli G, Marchetti B, Bernardi T Front Psychiatry. 2022; 13:875722.

PMID: 35530025 PMC: 9069068. DOI: 10.3389/fpsyt.2022.875722.

Acute DOB and PMA Administration Impairs Motor and Sensorimotor Responses in Mice and Causes Hallucinogenic Effects in Adult Zebrafish.

Tirri M, Ponzoni L, Bilel S, Arfe R, Braida D, Sala M Brain Sci. 2020; 10(9).

PMID: 32847111 PMC: 7563198. DOI: 10.3390/brainsci10090586.

Pharmacological Mechanisms Involved in Sensory Gating Disruption Induced by (±)-3,4-Methylene- Dioxymethamphetamine (MDMA): Relevance to Schizophrenia.

Lee J, Thwaites S, Gogos A, van den Buuse M Brain Sci. 2020; 10(1).

PMID: 31941052 PMC: 7016806. DOI: 10.3390/brainsci10010044.

Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe.

Miliano C, Marti M, Pintori N, Castelli M, Tirri M, Arfe R Front Pharmacol. 2020; 10:1406.

PMID: 31915427 PMC: 6921684. DOI: 10.3389/fphar.2019.01406.

nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.

Parikh V, Kutlu M, Gould T Schizophr Res. 2016; 171(1-3):1-15.

PMID: 26803692 PMC: 4762752. DOI: 10.1016/j.schres.2016.01.020.

References

Cadenhead K, Light G, Geyer M, Braff D . Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry. 2000; 157(1):55-9. DOI: 10.1176/ajp.157.1.55. View

Weike A, Bauer U, Hamm A . Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiatry. 2000; 47(1):61-70. DOI: 10.1016/s0006-3223(99)00229-2. View

Ellenbroek B, van Luijtelaar G, Frenken M, Cools A . Sensory gating in rats: lack of correlation between auditory evoked potential gating and prepulse inhibition. Schizophr Bull. 2000; 25(4):777-88. DOI: 10.1093/oxfordjournals.schbul.a033418. View

Parwani A, Duncan E, Bartlett E, Madonick S, Efferen T, Rajan R . Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry. 2000; 47(7):662-9. DOI: 10.1016/s0006-3223(99)00148-1. View

Cadenhead K, Swerdlow N, Shafer K, Diaz M, Braff D . Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am J Psychiatry. 2000; 157(10):1660-8. DOI: 10.1176/appi.ajp.157.10.1660. View

Swerdlow N, Braff D, Geyer M . Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol. 2000; 11(3-4):185-204. DOI: 10.1097/00008877-200006000-00002. View

Braff D, Geyer M, Light G, Sprock J, Perry W, Cadenhead K . Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res. 2001; 49(1-2):171-8. DOI: 10.1016/s0920-9964(00)00139-0. View

de Bruin N, Ellenbroek B, van Luijtelaar E, Cools A, Stevens K . Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell. Neuroscience. 2001; 105(1):169-80. DOI: 10.1016/s0306-4522(01)00183-x. View

Geyer M, Braff D, Swerdlow N . Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl). 2001; 156(2-3):117-54. DOI: 10.1007/s002130100811. View

10.

Swerdlow N, Geyer M, Braff D . Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl). 2001; 156(2-3):194-215. DOI: 10.1007/s002130100799. View

11.

Braff D, Geyer M, Swerdlow N . Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001; 156(2-3):234-58. DOI: 10.1007/s002130100810. View

12.

de Bruin N, van Luijtelaar E, Cools A, Ellenbroek B . Auditory information processing in rat genotypes with different dopaminergic properties. Psychopharmacology (Berl). 2001; 156(2-3):352-9. DOI: 10.1007/s002130100785. View

13.

Swerdlow N, Platten A, Shoemaker J, Pitcher L, Auerbach P . Effects of pergolide on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berl). 2001; 158(3):230-40. DOI: 10.1007/s002130100856. View

14.

Light G, Braff D . Measuring P50 suppression and prepulse inhibition in a single recording session. Am J Psychiatry. 2001; 158(12):2066-8. DOI: 10.1176/appi.ajp.158.12.2066. View

15.

Ludewig K, Geyer M, Etzensberger M, Vollenweider F . Stability of the acoustic startle reflex, prepulse inhibition, and habituation in schizophrenia. Schizophr Res. 2002; 55(1-2):129-37. DOI: 10.1016/s0920-9964(01)00198-0. View

16.

Cadenhead K, Light G, Geyer M, McDowell J, Braff D . Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype?. Am J Psychiatry. 2002; 159(5):869-71. DOI: 10.1176/appi.ajp.159.5.869. View

17.

Oranje B, van Oel C, Gispen-de Wied C, Verbaten M, Kahn R . Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. J Clin Psychopharmacol. 2002; 22(4):359-65. DOI: 10.1097/00004714-200208000-00005. View

18.

Myles-Worsley M . P50 sensory gating in multiplex schizophrenia families from a Pacific island isolate. Am J Psychiatry. 2002; 159(12):2007-12. DOI: 10.1176/appi.ajp.159.12.2007. View

19.

Grunwald T, Boutros N, Pezer N, von Oertzen J, Fernandez G, Schaller C . Neuronal substrates of sensory gating within the human brain. Biol Psychiatry. 2003; 53(6):511-9. DOI: 10.1016/s0006-3223(02)01673-6. View

20.

Shepard P, Joy B, Clerkin L, Schwarcz R . Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat. Neuropsychopharmacology. 2003; 28(8):1454-62. DOI: 10.1038/sj.npp.1300188. View